This important study provides a detailed analysis of the transcriptional landscape of the mouse hippocampus in the context of various physiological states. The main conclusions have solid support: ...
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company which is developing urcosimod to treat ...
Microglial activation is a determining factor that allows amyloid-beta accumulation to drive reactive astrogliosis, amplifying inflammatory responses in the brain. This was the conclusion of a study ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Product designation supports development of innovative investigational gene ...
Google is rolling out a change to how ads appear in Search, and this time it’s focused on clarity and user control. Text ads will now be grouped under a single “Sponsored results” label that stays ...
The Institute for Glial Sciences (IGS) is pleased to announce the inaugural Translational Glial Sciences (TGS) Conference, taking place November 4, 2025 from 12–6pm, at the Sheila and Eric Samson ...
The best label maker is a boost to your storage and organization efforts, whether that’s sorting a spice rack or slapping your kid’s name on their back-to-school stuff. It makes closets and drawers ...
Hosted on MSN
Blue Label secures majority Cell C stake
Blue Label has achieved majority ownership of Cell C. Blue Label has finally achieved its almost decade-long goal of securing a majority stake in Cell C, South Africa’s fourth biggest mobile operator, ...
Oligodendroglioma is a rare type of brain tumor. It’s in a category of brain and spinal cord tumors called gliomas. These are brain or spinal cord tumors that come from abnormal glial cells, the ...
JOHANNESBURG, Sept 1 (Reuters) - South Africa's Blue Label (BLUJ.J), opens new tab said on Monday that it plans a group restructuring to facilitate the unbundling and potential listing of mobile ...
Hosted on MSN
Blue Label readies for Cell C listing to clear debt
Blue Label Telecoms currently owns 49.5% of Cell C and is seeking final regulatory approval to buy an additional 4.04% stake. (Photograph by Lesley Moyo) Blue Label Telecoms has started making plans ...
Scientists have developed a groundbreaking cryo-optical microscopy technique that freezes living cells mid-action, capturing ultra-detailed snapshots of fast biological processes. By rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results